Activation of the androgen receptor by polypeptide growth factors and cellular regulators
Z Culig1, A Hobisch, M V Cronauer
1Department of Urology, University of Innsbruck, Austria.
Abstract:
The polypeptide growth factors insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and transforming growth factor-alpha (TGF-alpha); second-messenger cyclic adenosine monophosphate (cAMP): protein kinase activators; and neurotransmitters were found to activate the estrogen (ER), progesterone (PR), and glucocorticoid receptor (GR) either in the absence of their natural ligands or synergistically with the respective hormone. There is now evidence of coupling of signaling pathways involving the androgen receptor (AR). Three polypeptide growth factor, IGF-I, keratinocyte growth factor (KGF), and EGF, stimulated AR-mediated reporter-gene transcription in the absence of androgen in DU-145 cells, which were cotransfected with the reporter gene and an AR expression vector. IGF-I effects were observed irrespective of the promoter driving the reporter gene. This growth factor increased the prostate-specific antigen (PSA) level in LNCaP cells, which contain endogenous AR. In CV-1 cells, which transiently express the AR, second-messenger cAMP potentiated effects of testosterone in stimulation of AR-mediated reporter-gene activity. Inhibition of androgen-stimulated chloramphenicol acetyltransferase (CAT) activity in the LNCaP cell line was achieved with retinoic acid. Stimulation and inhibition of prostatic carcinoma cell growth by polypeptide growth factors and cellular regulators may depend on the presence of the AR in an androgen-depleted environment.
Insights
Growth factors and signaling molecules can activate hormone receptors like the androgen receptor (AR) without hormones. This influences prostate cancer cell growth, even in low-androgen conditions.
Area of Science:
- Molecular Endocrinology
- Cell Signaling
- Cancer Biology
Background:
- Hormone receptors (ER, PR, GR) are activated by growth factors, cAMP, and neurotransmitters.
- Emerging evidence suggests similar cross-talk with the androgen receptor (AR).
Purpose of the Study:
- To investigate the role of growth factors and signaling molecules in activating the androgen receptor (AR).
- To explore the impact of AR activation on prostate cancer cell growth in androgen-depleted environments.
Main Methods:
- Reporter-gene assays in DU-145 and CV-1 cells to measure AR-mediated transcription.
- Prostate-specific antigen (PSA) level measurement in LNCaP cells.
- Assessing the effect of retinoic acid on androgen-stimulated activity.
Main Results:
- Polypeptide growth factors (IGF-I, KGF, EGF) stimulated AR-mediated transcription without androgens.
- IGF-I increased PSA levels in LNCaP cells.
- cAMP potentiated testosterone's effect on AR activity.
- Retinoic acid inhibited androgen-stimulated activity.
Conclusions:
- Signaling pathways involving the AR can be activated by growth factors and second messengers independently of androgens.
- AR activation in an androgen-depleted environment may influence prostatic carcinoma cell growth.
More Related Videos
Related Concept Videos
Internal Receptors
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Signal Transduction: Overview
Typically, signal transduction involves three...


